| [1] |
World Health Organization. Global tuberculosis report 2025[EB/OL]. (2025-11-12) [2026-05-28]. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025.
|
| [2] |
中华人民共和国国家卫生和计划生育委员会. 中华人民共和国卫生行业标准肺结核诊断: WS 288—2017[EB/OL]. (2017-12-12)[2026-05-28]. http://www.nhfpc.gov.cn/zhuz/s9491/201712/a452586fd21d4018b0ebc00b89c06254.shtml.
|
|
National Health and Family Planning Commission of the People's Republic of China. Health industry standard of the people's republic of China: diagnosis of pulmonary tuberculosis:WS 288—2017 [EB/OL]. (2017-12-12)[2026-05-28]. http://www.nhfpc.gov.cn/zhuz/s9491/201712/a452586fd21d4018b0ebc00b89c06254.shtml.
|
| [3] |
Rabello E, De-Paris F. Tuberculosis diagnostic methods:clinical applicability,implementation challenges,and integrated testing strategies[J]. Pathogens, 2026, 15(2):142. doi:10.3390/pathogens15020142.
|
| [4] |
Chen Z, Kong X, Ma Q, et al. The impact of Mycobacterium tuberculosis on the macrophage cholesterol metabolism pathway[J]. Front Immunol, 2024, 15:1402024. doi:10.3389/fimmu.2024.1402024.
|
| [5] |
Van der Klugt T, Van den Biggelaar R H G A, Saris A. Host and bacterial lipid metabolism during tuberculosis infections:possibilities to synergise host- and bacteria-directed therapies[J]. Crit Rev Microbiol, 2025, 51(3):463-483. doi:10.1080/1040841X.2024.2370979.
|
| [6] |
Zhu C, Chen J, Li Y, et al. Robust diagnostic and therapeutic biomarkers for tuberculosis identified through multi-omics and mendelian randomization analysis[J]. MedComm, 2025, 7(1):e70559. doi:10.1002/mco2.70559.
|
| [7] |
Otchere I D, Aboagye S Y, Arthur P K, et al. Viewpoint of multi-omics potential in tuberculosis research:identifying biomarkers for biomanufacturing of efficient control tools[J]. Front Trop Dis, 2024, 5:1443248. doi:10.3389/fitd.2024.1443248.
|
| [8] |
Zhao W, Yan P, Pei Y, et al. Lipidomics-based identification of plasma lipid biomarkers in tuberculosis-coronary artery disease comorbidity[J]. Infect Drug Resist, 2025, 18:6577-6590. doi:10.2147/IDR.S558880.
|
| [9] |
Muwanga V M, Mendelsohn S C, Leukes V, et al. Blood transcriptomic signatures for symptomatic tuberculosis in an African multicohort study[J]. Eur Respir J, 2024, 64(2):2400153. doi:10.1183/13993003.00153-2024.
|
| [10] |
韦金涛, 李华, 邱恩明. 结核病的代谢组学研究进展[J]. 中国防痨杂志, 2018, 40(11):1226-1230.
|
|
Wei J T, Li H, Qiu E M. Progress in metabolomics research on tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(11):1226-1230. doi:10.3969/j.issn.1000-6621.2018.11.015.
|
| [11] |
Yu Y, Jiang X X, Li J C. Biomarker discovery for tuberculosis using metabolomics[J]. Front Mol Biosci, 2023, 10:1099654. doi:10.3389/fmolb.2023.1099654.
|
| [12] |
Dineen R A, Martin-Grace J, Ahmed K M S, et al. Tissue glucocorticoid metabolism in adrenal insufficiency:a prospective study of dual-release hydrocortisone therapy[J]. J Clin Endocrinol Metab, 2023, 108(12):3178-3189. doi:10.1210/clinem/dgad370.
|
| [13] |
Pérez A R, Bottasso O A, Santucci N E. Immune-endocrine crossroads:the impact of nuclear receptors in tuberculosis and chagas disease[J]. Front Endocrinol, 2025, 16:1538376. doi:10.3389/fendo.2025.1538376.
|
| [14] |
Gonzalez-Muñiz O E, Rodriguez-Carlos A, Santos-Mena A, et al. Metformin modulates corticosteroids hormones in adrenals cells promoting mycobacterium tuberculosis elimination in human macrophages[J]. Tuberculosis, 2024, 148:102548. doi:10.1016/j.tube.2024.102548.
|
| [15] |
Maceiras A R, Silva M L, Couto J, et al. Activation of nuclear receptors correlates with tuberculosis severity and is a target for host-directed therapy[J]. Front Cell Infect Microbiol, 2025, 15:1724798. doi:10.3389/fcimb.2025.1724798.
|
| [16] |
Liu J, Sun J, Yu J, et al. Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism[J]. NPJ Biofilms Microbiomes, 2023, 9(1):29. doi:10.1038/s41522-023-00399-z.
|
| [17] |
Sun G, Wang Q, Shan X, et al. Metabolomics and lipidomics of plasma biomarkers for tuberculosis diagnostics using UHPLC-HRMS[J]. Front Cell Infect Microbiol, 2025, 15:1526740. doi:10.3389/fcimb.2025.1526740.
|
| [18] |
曾忠花, 刘容容, 汤俐, 等. 肠道菌群与胆汁酸代谢的互相作用[J]. 中国微生态学杂志, 2021, 33(7):849-856.
|
|
Zeng Z H, Liu R R, Tang L, et al. Interaction between gut microbiota and bile acid metabolism[J]. Chin J Microecol, 2021, 33(7):849-856. doi:10.13381/j.cnki.cjm.202107022.
|
| [19] |
Wang K, Xu X, Shan Q, et al. Integrated gut microbiota and serum metabolomics reveal the protective effect of oleanolic acid on liver and kidney-injured rats induced by euphorbia pekinensis[J]. Phytother Res, 2024, 38(10):4877-4892. doi:10.1002/ptr.7673.
|
| [20] |
Prabutzki P, Schiller J, Engel K M. Phospholipid-derived lysophospholipids in (patho)physiology[J]. Atherosclerosis, 2024, 398:118569. doi:10.1016/j.atherosclerosis.2024.118569.
|
| [21] |
Wood P L, Tippireddy S, Feriante J. Plasma lipidomics of tuberculosis patients:altered phosphatidylcholine remodeling[J]. Future Sci OA, 2018, 4(1):FSO255. doi:10.4155/fsoa-2017-0011.
|
| [22] |
Zhang C, Cai M, Cai H, et al. Plasma lipidomic analysis reveals distinct lipid alterations in patients with pulmonary tuberculosis[J]. Eur J Med Res, 2025, 30(1):566. doi:10.1186/s40001-025-02835-6.
|
| [23] |
林东子, 王威, 邱峰, 等. 基于LC-MS筛选肺结核耐药患者的血清代谢标志物[J]. 南方医科大学学报, 2019, 39(12):1409-1420.
|
|
Lin D Z, Wang W, Qiu F, et al. Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis[J]. J South Med Univ, 2019, 39(12):1409-1420. doi:10.12122/j.issn.1673-4254.2019.12.04.
|
| [24] |
Hayton J B, Ward B T, Elnaas A R, et al. Isolation of the 3′R and 3′S diastereomers of fasciculic acid C from the Australian mushroom hypholoma Australianum[J]. Tetrahedron Lett, 2021, 78:153294. doi:10.1016/j.tetlet.2021.153294.
|
| [25] |
王宏杰, 邹映雪, 穆世茵, 等. 儿童肺结核45例临床特点及诊断分析[J]. 天津医药, 2022, 50(12):1316-1319.
|
|
Wang H J, Zou Y X, Mu S Y, et al. Clinical features and diagnostic analysis of 45 children with pulmonary tuberculosis[J]. Tianjin Med J, 2022, 50(12):1316-1319. doi:10.11958/20220516.
|
| [26] |
Kasule G W, Hermans S, Semugenze D, et al. Non-sputum-based samples and biomarkers for detection of mycobacterium tuberculosis:the hope to improve childhood and HIV-associated tuberculosis diagnosis[J]. Eur J Med Res, 2024, 29(1):502. doi:10.1186/s40001-024-02092-z.
|